GNI Group Ltd. (TYO:2160)
2,900.00
-68.00 (-2.29%)
Aug 12, 2025, 3:30 PM JST
GNI Group Market Cap
GNI Group has a market cap or net worth of 161.10 billion as of August 12, 2025. Its market cap has increased by 20.12% in one year.
Market Cap
161.10B
Enterprise Value
160.35B
Revenue
22.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,900.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 161.10B, an increase of 2,976.87%. That is a compound annual growth rate of 21.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 161.10B | -5.65% |
Dec 30, 2024 | 170.75B | 21.35% |
Dec 29, 2023 | 140.72B | 112.73% |
Dec 30, 2022 | 66.15B | -5.89% |
Dec 30, 2021 | 70.29B | -10.65% |
Dec 30, 2020 | 78.67B | -30.85% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 10.03T |
Takeda Pharmaceutical Company | 6,661.90B |
HOYA Corporation | 6,639.23B |
Daiichi Sankyo Company | 6,570.84B |
Otsuka Holdings | 4,125.23B |
Terumo | 4,035.01B |
Astellas Pharma | 2,892.25B |
Shionogi & | 2,245.22B |